Skip to main content

ZURZUVAE is the first and only
FDA-approved oral treatment
for adults with postpartum
depression (PPD).

Actor Portrayal

ZURZUVAE (zur-ZOO-vay) is a prescription medicine. Speak to your healthcare provider to see if ZURZUVAE® (zuranolone) is right for you.

ZURZUVAE is a 14-day treatment that may offer relief starting in 3 days

It’s taken for 14 days

Here’s what to keep in mind
about treatment

Get the details
Rapid relief starting
at day 3

In a clinical study, ZURZUVAE
improved symptoms at day 15,
and as fast as day 3

See the results

ZURZUVAE 50 mg was studied in women with PPD whose symptoms started in the third trimester or within 4 weeks of delivery in a 6-week trial. During the trial, patients took either ZURZUVAE or placebo for 14 days, and were followed up for another 4 weeks. Significantly greater PPD symptom improvement was demonstrated at Day 3, Day 15 (the primary endpoint), and Day 45 compared to placebo, using a standard depression rating scale.

ZURZUVAE For You is a patient support program that
is here to help as you navigate your
ZURZUVAE treatment journey.

Actor Portrayal

Stay up to date with details about ZURZUVAE